Annual Total Debt
$404.78 M
-$2.70 M-0.66%
December 31, 2023
Summary
- As of February 7, 2025, TVTX annual total debt is $404.78 million, with the most recent change of -$2.70 million (-0.66%) on December 31, 2023.
- During the last 3 years, TVTX annual total debt has risen by +$160.75 million (+65.87%).
- TVTX annual total debt is now -0.66% below its all-time high of $407.49 million, reached on December 31, 2022.
Performance
TVTX Total Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Debt
$402.43 M
-$792.00 K-0.20%
September 30, 2024
Summary
- As of February 7, 2025, TVTX quarterly total debt is $402.43 million, with the most recent change of -$792.00 thousand (-0.20%) on September 30, 2024.
- Over the past year, TVTX quarterly total debt has dropped by -$2.35 million (-0.58%).
- TVTX quarterly total debt is now -1.55% below its all-time high of $408.79 million, reached on March 31, 2022.
Performance
TVTX Quarterly Total Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Debt Formula
Total Debt = Short Term Debt + Long Term Debt
TVTX Total Debt Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -0.7% | -0.6% |
| 3 y3 years | +65.9% | -1.2% |
| 5 y5 years | +86.1% | -1.2% |
TVTX Total Debt Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -0.7% | +54.5% | -1.6% | +53.6% |
| 5 y | 5-year | -0.7% | +97.6% | -1.6% | +96.4% |
| alltime | all time | -0.7% | -100.0% | -1.6% | -100.0% |
Travere Therapeutics Total Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $402.43 M(-0.2%) |
| Jun 2024 | - | $403.23 M(-0.2%) |
| Mar 2024 | - | $404.02 M(-0.2%) |
| Dec 2023 | $404.78 M(-0.7%) | $404.78 M(-0.2%) |
| Sep 2023 | - | $405.48 M(-0.2%) |
| Jun 2023 | - | $406.17 M(-0.2%) |
| Mar 2023 | - | $406.85 M(-0.2%) |
| Dec 2022 | $407.49 M(+55.5%) | $407.49 M(-0.0%) |
| Sep 2022 | - | $407.62 M(-0.1%) |
| Jun 2022 | - | $408.17 M(-0.2%) |
| Mar 2022 | - | $408.79 M(+56.0%) |
| Dec 2021 | $261.99 M(+7.4%) | $261.99 M(+17.1%) |
| Sep 2021 | - | $223.70 M(+1.3%) |
| Jun 2021 | - | $220.86 M(+1.3%) |
| Mar 2021 | - | $218.08 M(-10.6%) |
| Dec 2020 | $244.03 M(+19.1%) | $244.03 M(+14.8%) |
| Sep 2020 | - | $212.65 M(+1.3%) |
| Jun 2020 | - | $210.01 M(+1.3%) |
| Mar 2020 | - | $207.41 M(+1.2%) |
| Dec 2019 | $204.86 M(-5.8%) | $204.86 M(+1.2%) |
| Sep 2019 | - | $202.35 M(+1.2%) |
| Jun 2019 | - | $199.89 M(-9.1%) |
| Mar 2019 | - | $220.01 M(+1.1%) |
| Dec 2018 | $217.55 M(+382.6%) | $217.55 M(+1.1%) |
| Sep 2018 | - | $215.13 M(+373.8%) |
| Jun 2018 | - | $45.40 M(+0.4%) |
| Mar 2018 | - | $45.24 M(+0.4%) |
| Dec 2017 | $45.08 M | $45.08 M(+0.4%) |
| Sep 2017 | - | $44.91 M(+0.4%) |
| Jun 2017 | - | $44.75 M(+0.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2017 | - | $44.58 M(+0.4%) |
| Dec 2016 | $44.42 M(+1.5%) | $44.42 M(+0.4%) |
| Sep 2016 | - | $44.26 M(+0.4%) |
| Jun 2016 | - | $44.09 M(+0.4%) |
| Mar 2016 | - | $43.93 M(+0.4%) |
| Dec 2015 | $43.77 M(-47.8%) | $43.77 M(+0.0%) |
| Sep 2015 | - | $43.75 M(-48.4%) |
| Jun 2015 | - | $84.72 M(+0.6%) |
| Mar 2015 | - | $84.24 M(+0.6%) |
| Dec 2014 | $83.77 M(>+9900.0%) | $83.77 M(+0.6%) |
| Sep 2014 | - | $83.29 M(+0.6%) |
| Jun 2014 | - | $82.81 M(+164.7%) |
| Mar 2014 | - | $31.28 M(>+9900.0%) |
| Dec 2013 | $0.00(-100.0%) | $0.00(0.0%) |
| Sep 2013 | - | $0.00(0.0%) |
| Jun 2013 | - | $0.00(0.0%) |
| Mar 2013 | - | $0.00(-100.0%) |
| Dec 2012 | $884.80 K(+3439.2%) | - |
| Nov 2012 | - | $25.00 K(0.0%) |
| Aug 2012 | - | $25.00 K(0.0%) |
| May 2012 | - | $25.00 K(0.0%) |
| Feb 2012 | - | $25.00 K(0.0%) |
| Feb 2012 | $25.00 K(0.0%) | - |
| Nov 2011 | - | $25.00 K(>+9900.0%) |
| Aug 2011 | - | $0.00(0.0%) |
| May 2011 | - | $0.00(-100.0%) |
| Feb 2011 | $25.00 K | $25.00 K(>+9900.0%) |
| Nov 2010 | - | $0.00(0.0%) |
| Aug 2010 | - | $0.00(0.0%) |
| May 2010 | - | $0.00 |
FAQ
- What is Travere Therapeutics annual total debt?
- What is the all time high annual total debt for Travere Therapeutics?
- What is Travere Therapeutics annual total debt year-on-year change?
- What is Travere Therapeutics quarterly total debt?
- What is the all time high quarterly total debt for Travere Therapeutics?
- What is Travere Therapeutics quarterly total debt year-on-year change?
What is Travere Therapeutics annual total debt?
The current annual total debt of TVTX is $404.78 M
What is the all time high annual total debt for Travere Therapeutics?
Travere Therapeutics all-time high annual total debt is $407.49 M
What is Travere Therapeutics annual total debt year-on-year change?
Over the past year, TVTX annual total debt has changed by -$2.70 M (-0.66%)
What is Travere Therapeutics quarterly total debt?
The current quarterly total debt of TVTX is $402.43 M
What is the all time high quarterly total debt for Travere Therapeutics?
Travere Therapeutics all-time high quarterly total debt is $408.79 M
What is Travere Therapeutics quarterly total debt year-on-year change?
Over the past year, TVTX quarterly total debt has changed by -$2.35 M (-0.58%)